Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ARC2 Communications & Media was a boutique healthcare public relations and communications agency based in Los Angeles, California. Founded in 2013 by former Hill+Knowlton Strategies executives Christine Cassiano and Andrea Rothschild, the firm specialized in providing strategic communications, media relations, and issues management for the biotechnology, pharmaceutical, and medical device industries. The agency leveraged the founders' extensive experience at major life science companies like Amgen and Allergan to offer high-level counsel to emerging and established healthcare brands. The firm was recognized for its ability to navigate complex regulatory environments and manage product lifecycles for life science clients. In February 2015, ARC2 was acquired by W2O Group (now Real Chemistry) to expand its West Coast presence and bolster its healthcare content and digital communications capabilities. Following the acquisition, the firm's leadership and expertise were integrated into W2O's broader healthcare practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ARC2 Communications & Media.